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Background: Disinfectants with claimed activity against Clostridium difficile must be
evaluated to ensure efficacy against the spores that comprise an environmental source of
patient infection. Unfortunately there is, at present, no generally accepted method for
evaluating these disinfectants. In the absence of such a method, laboratories have to
adapt protocols that were not designed for products used in medical environments and
consequently may use inappropriate test organisms, exposure times, and pass criteria.
Aim: To develop and evaluate a method for testing the activity of disinfectants against
C. difficile spores using exposure times and pass criteria which are relevant to clinical
application.
Methods: A Joint Working Party of the Healthcare Infection Society (HIS) and the Advisory
Committee on Antimicrobial Resistance and Healthcare Associated Infections (ARHAI) of
the Department of Health in England was assembled. The Working Party adapted a pre-
viously described enzyme-based method for spore purification (the Clospore method) using
an exposure time of 5min and a 5 log10 kill as a pass criterion.
Findings: Evaluation of the method by three laboratories demonstrated that the method is
simple to follow and that the results are repeatable and reproducible.
Conclusion: The method described by the Working Party produces a clean suspension with
a high titre of spores. It is recommended that, for a disinfectant used in the environment,
the product should demonstrate a 5 log10 reduction in 5min under clean or dirty conditions
to fulfil the requirements of the test.
ª 2014 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.112113
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For some time, concerns have been expressed about the
validity of tests that measure the activity of disinfectants
against Clostridium difficile spores.1‒3 When C. difficile was
highly prevalent in UK hospitals, many companies introduced
products claiming to be active against spores of C. difficile. In
the absence of a standard test against this organism, it was
difficult for infection prevention and control teams to make an
informed decision on the efficacy of these products and to
make comparisons. Although a European Standard for spori-
cidal activity (EN 13704, 2002) exists, this uses Bacillus subtilis
and Clostridium sporogenes rather than a clinically relevant
strain such as C. difficile as the test organism.4 This European
standard has also been designed for use in food hygiene, do-
mestic, and institutional settings rather than in the healthcare
environment. Consequently, themandatory exposure time, i.e.
60 min, is too long to be representative of clinical use of dis-
infectants, and the conditions of the test only include a low soil
(clean conditions) for pre-cleaned surfaces ‒ a challenge for
any disinfectant in the presence of high soil (dirty conditions)
reflects the real world where organic material frequently
contaminates inanimate surfaces. Furthermore, EN 13704 only
requires a 3 log10 reduction in order for a product to fulfil the
requirements of the standard, whereas a 5 log10 reduction is
generally thought to be more appropriate for a product in
clinical use. The 5 log10 reduction is of particular importance
for C. difficile as the infective dose, according to animal ex-
periments, is extremely low.4,5
Of concern is the fact that a suspension of C. difficile with
a high titre can be difficult to prepare, and that tests using a
suspension consisting predominantly of vegetative cells will
give misleading results as vegetative cells are much more
susceptible to chemical disinfection than spores.6 Conse-
quently, a testing laboratory with poor technique might
prepare test suspensions that have a low proportion of spores
and could therefore erroneously report successful sporicidal
activity in a product that will be of little use in a clinical
environment. Validation of neutralization of residual disin-
fectant and possible toxicity of the neutralizer are crucial
when testing chemical disinfectants. Laboratories with poor
technique may also overestimate the activity of a product by
inadequately neutralizing the disinfectant, resulting in an
effective exposure time in excess of that stated in the
standard.
In light of the above concerns, a Joint Working Party of the
Department of Health (England) Advisory Committee on Anti-
microbial Resistance and Healthcare Associated Infection
(ARHAI) and the Healthcare Infection Society was set up in
2011. The Task Force initially reviewed the published methods
for preparation of C. difficile test spores and developed a
reliable and reproducible method for testing disinfectant ac-
tivity against this clinically important organism. The method
was trialled in three different laboratories [School of Pharmacy
and Pharmaceutical Sciences, Cardiff University; the Hospital
Infection Research Laboratory (HIRL), Queen Elizabeth Hospi-
tal, Birmingham; and the Public Health England Laboratory
(PHE), Porton Down]. Technical difficulties were identified and
reasons for discrepancies between laboratories were investi-
gated. An iterative process allowed the methodology to be
improved and a final method was evaluated.Please cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014The protocol is now complete and the rationale underlying
the chosen method is described as follows.
Rationale underlying the test method
Currently there is no European sporicidal disinfectant test
applicable to the medical area; thus, the protocol most often
adapted to test activity against C. difficile spores is EN 13704
(2002), which is not an ideal test for the following reasons:
e It uses Bacillus subtilis and Clostridium sporogenes spores,
which are not representative of the clinical scenario. There
is a need for a test that uses C. difficile rather than a
surrogate organism.
e It requires a 3 log10 spore kill to pass, which is insufficient to
be relevant for a product designed for use in the medical
area. The levels of C. difficile spores isolated from
environmental surfaces, particularly during an outbreak,
may be high.5e11
e It uses an obligatory contact time of 60min to determine a
pass or a fail. Most situations where sporicidal activity
against C. difficile would be required involve a liquid
disinfectant applied to environmental surfaces, which is
then allowed to dry naturally. This would take seconds to a
few minutes.
e This test only has a simulation of clean conditions (0.3 g/L
albumin in the test mixture). This provides a less stringent
challenge than many of the situations in which a sporicidal
disinfectant would be expected to work in healthcare
where an organic load would be present.
For the above reasons the Joint Working Party developed a
method for spore preparation and activity testing which is
more relevant to products designed for medical use. The test
proposed incorporates the following features:
e It uses a non-toxigenic strain of C. difficile. There is no
reason to suspect that toxigenesis coincides with decreased
susceptibility to disinfectants. Using a non-toxigenic strain
decreases laboratory safety constraints, meaning that it
will be a feasible test for a wider range of laboratories.
e It has a detailed and validated method for spore prepara-
tion incorporating growth, harvesting, purification, and
verification. This protocol uses a culture method that yields
increased spore numbers, and incorporates enzymatic
purification and ultrasonic homogenization steps to give a
high yield of spores with very low numbers of vegetative
cells. This is verified by phase-contrast microscopy.
e This method gives a highly purified spore suspension with
little extraneous matter that may interfere with a biocidal
product’s activity.
e The titre of the spore suspension allows a 5 log10 reduction
of spores to be demonstrated as a pass level; a target that is
more relevant to patient safety than the previous 3 log10
reduction.
e The exposure time used is 5 min. This represents the short-
term exposure of spores to liquid disinfectant during sur-
face disinfection in a clinical setting more realistically than
the 60 min in EN 13704.
e The test has both clean (0.3 g/L albumin) and dirty (3.0 g/L
albumin plus 3.0 mL/L sheep erythrocytes) conditions130
idal test method for Clostridium difficile, Journal of Hospital Infection
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YJHIN4416_proof ■ 13 November 2014 ■ 3/14included in the method to simulate that which would be
found in the healthcare environment.
e The test incorporates an internal control using a standard
500 ppm available chlorine solution. This provides verifi-
cation of the disinfectant susceptibility of the spore
suspension.Table I
Summary of log10 reduction in Clostridium difficile spores
following exposure to sodium dichloroisocyanurate at 500 ppm
Laboratory Log10 reduction at time
Batch 1 Batch 2
1 min 5min 60min 1 min 5 min 60 min
Laboratory 1
Mean 0.64 1.19 6.34 0.38 0.87 5.98
SD 0.18 0.20 0.15 0.05 0.18 0.19
Laboratory 2
Mean 0.55 3.07 6.21 0.50 2.06 6.78
SD 0.10 0.58 0.79 0.05 0.11 0.34
Laboratory 3
Mean 0.73 1.51 5.65 0.69 1.41 4.56
SD 0.35 0.51 0.14 0.20 0.55 0.07
Overall mean 0.63 1.91 6.00 0.52 1.46 5.71
Overall SD 0.24 0.92 0.46 0.18 0.59 0.89
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C. difficile spores
The methodology developed was based upon the work of
Perez et al., who demonstrated that the use of Clospore me-
dium, along with an enzyme purification step, allowed the
production of C. difficile spore suspensions at titres of up to 109
(9 log10) of 90% purity (as assessed by phase-contrast micro-
scopy).12 C. difficile, NCTC 11209, was incubated anaerobically
using Clospore medium, either in liquid or solid form, for 7‒10
days. The organism was recovered and concentrated using
several washing/centrifugation steps, prior to a purification
step involving the use of an enzyme preparation and ultra-
sonication, to break up spore aggregates, and digest any
vegetative cells. The suspension was then washed/centrifuged
several more times before being heat-shocked at 70C for
10min to kill any remaining vegetative cells. After a final round
of washing/centrifugation, the purity of the spore preparation
was checked using phase-contrast microscopy, and the titre
ascertained with conventional culture methods.
Test method for measuring the activity of
chemical disinfectants against C. difficile spores
In order to verify the methodology, a multicentre trial was
set up involving three laboratories (HIRL, Cardiff University and
PHE). The intention was to test one disinfectant product using
the spore preparation method and the disinfectant test
described in Appendix 1.
Each laboratory tested a 500 ppm available chlorine solution
prepared from sodium dichloroisocyanurate (NaDCC) tablets.
The concentration of available chlorine was determined prior
to testing using a standard pharmacopoeial method.13 The test
was carried out under clean conditions only, i.e. in the pres-
ence of 0.3 g/L bovine serum albumin. Contact times of 1, 5,
and 60 min were tested to allow for low and high reductions to
be detected. Each laboratory carried out the test in triplicate
on each of two separate days. Each test was carried out using
two separate batches of spore suspension. Further tests were
also carried out to determine the shelf life of the spore sus-
pension; i.e. to what extent the spore titre decreased over
time.
The European Standard methods for disinfectant testing
involve the following: 8 mL of NaDCC (500 ppm final concen-
tration) mixed with 1 mL of organic load (0.03% w/v albumin;
final concentration) and 1mL of spore suspension. After pre-
defined contact times 1 mL was removed and added to a pre-
viously validated neutralizing solution. The number of surviving
spores was enumerated and the log10 reduction calculated. The
organic load used was as described in other standards used for
assessing disinfectants for the medical area.
The results from these laboratories were analysed as per
ASTM E691-12, to establish accuracy, repeatability andPlease cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014reproducibility.14 These tests were also used as the basis for
inclusion of an internal control for all tests with C. difficile
spores.
Results
The summary of the results obtained is displayed in Table I
and Figure 1. The greatest variability was seen at 5 min; this
may represent a critical time, where small variations in the
time taken to remove the spores to the recovery medium
translate to quite large differences in the amount of viable
spores remaining.
Figure 2 shows the h-statistic for the study, which repre-
sents the between-laboratory consistency found in the results.
Figure 3 shows the k-statistic for the study, which represents
the within-laboratory consistency of the data. In general, the k
and h values did not differ significantly at the 0.5% level. Using
these statistics, the 95% repeatability (r) and reproducibility
(R) limits were calculated (Table II). The 95% repeatability (r)
limit represents the value below which the absolute difference
between two individual test results obtained within the same
laboratory, by the same operator, may be expected to occur
with a probability of w0.95. Likewise, the 95% reproducibility
(R) limit represents the value below which the absolute dif-
ference between two individual test results obtained within
different laboratories, by different operators, may be ex-
pected to occur with a probability ofw0.95.
Conclusions and recommendations
The Clospore method for the preparation of spore suspen-
sions was found to be appropriate, although the quality of the
spore suspension should be verified using phase-contrast mi-
croscopy. The use of the Closporemethod repeatedly generated
a high titre of spores to be used in the suspension test. Testing
three contact times was shown to be important, since some
variability resulting in decreased repeatability and reproduc-
ibility in results was observed at a 5min contact time. As only a
small number of laboratories have taken part in this study, the
precision statistics should be interpreted with care; they are a
general guide to what may be expected. Nevertheless theidal test method for Clostridium difficile, Journal of Hospital Infection
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Figure 1. Summary of inter-laboratory results of 500 ppm chlorine-releasing agent against Clostridium difficile. HIRL, Hospital Infection
Research Laboratory; PHE, Public Health England; CU, Cardiff University.
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YJHIN4416_proof ■ 13 November 2014 ■ 4/14results in Table II suggest that the method proposed gives an
acceptable level of repeatability and reproducibility.
Based on the results of this study, the Clospore method is
recommended for spore preparation. It is also recommended
that an internal control comprising 500 ppm NaDCC (or other
equivalent chlorine-releasing agent) under clean conditions be
included in all testing of C. difficile spores. For a spore sus-
pension to be regarded as a sufficiently stringent challenge, the
internal control should not produce a >1 log10 reduction after
1 min. It is expected that the internal control would produce a
5 log10 reduction after 60min. Failure to do so may represent
excessive debris/clumping within the spore suspension.
This study has demonstrated that the Clospore method
produces a clean suspension with a sufficient number of spores
that can be used to demonstrate a 5 log10 reduction. The Joint
Working Party recommends that, for a disinfectant used in the
environment, the product should demonstrate a 5 log10
reduction in 5 min under clean or dirty conditions to fulfil the
requirements of the test. This requirement is in line with the
EN test for bactericidal efficacy. Five minutes is a more prac-
ticable time for disinfectants used for this purpose.Please cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014Conflict of interest statement
The views expressed in this publication are those of the
authors and not necessarily those of Public Health England
or any other Government Agency.
Funding sources Q
The Joint Working Party received funding to cover travel and
other expenses from the Healthcare Infection Society.Appendix 1. Test methodology for assessing the
efficacy of chemical disinfectants used in the
medical area against spores of Clostridium
difficile
Requirements
The product shall demonstrate 5 log10 reduction in 5 min,
when tested under simulated clean conditions (0.3 g/L bovine
albumin solution) or dirty conditions (3 g/L bovine albumin so-
lution, plus 3 mL/L washed sheep erythrocytes). For instrumentidal test method for Clostridium difficile, Journal of Hospital Infection
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Figure 2. h-Statistic for the study, representing the between-laboratory consistency found in the results.
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YJHIN4416_proof ■ 13 November 2014 ■ 5/14disinfectants, where recommended by the manufacturer to be
used at higher temperatures, the product needs to demonstrate
the 5 log10 reduction only at the recommended temperature.
Test conditions
Instrument disinfection or surface disinfection.
Test organism: Clostridium difficile NCTC 11209.
Test temperature and time
At the lowest recommended temperature, range 20‒60C,
contact time:
(a) obligatory 5 min;
(b) additional according to the manufacturer’s recommenda-
tion, but no longer than 5min.127
128
129
130Interfering substance(s)
Clean conditions: 0.3 g/L bovine albumin solution.Please cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014Dirty conditions: 3.0 g/L bovine albumin solution plus
3.0 mL/L washed sheep erythrocytes.
The obligatory contact times for surface disinfectants are
chosen on the basis of expected practical application of the
product.
Test method
Principle
A sample of the product as delivered and/or diluted with
hard water is added to a test suspension of spores in a solution
containing an interfering substance. The mixture is maintained
at the temperature for the contact time specified. At the end
of this contact time, an aliquot is taken and immediately
neutralized or suppressed by a validated method. The method
of choice is dilution‒neutralization. If a suitable neutralizer
cannot be found, membrane filtration may be used. The
numbers of surviving spores in each sample are determined and
the reduction is calculated.idal test method for Clostridium difficile, Journal of Hospital Infection
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Figure 3. k-Statistic for the study, representing the within-laboratory consistency of the data.
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Test organism: C. difficile NCTC 11209.
The required incubation temperature and conditions for this
test organism are 36 1C in anaerobic conditions for five days.
Culture media and reagents
General. All weights of chemical substances given in this SOP
refer to the anhydrous salts. Hydrated forms may be used as an
alternative, but the weights required shall be adjusted to allow
for consequent molecular weight differences.Table II
Reproducibility and repeatability limits for the inter-laboratory
study
1min 5 min 60 min
Reproducibility limits (R) 0.55 2.44 2.36
Repeatability limits (r) 0.55 1.68 1.47
122
123
124
125
126
127
128
129
130
Please cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014The reagents shall be of analytical grade and/or appropriate
for microbiological purposes. They shall be free from sub-
stances that are toxic or inhibitory to the test organism.
Note 1: To improve reproducibility, it is recommended that
commercially available dehydrated material be used for the
preparation of culture media. The manufacturer’s instructions
relating to the preparation of these products should be rigor-
ously followed.
Note 2: For each culture medium and reagent, a time limi-
tation for use should be fixed.
Water. The water shall be demineralized water (ultrapure
water) or freshly glass-distilled water. Water for injections may
be used.
Sterilize in the autoclave. If the water is used for prepara-
tion of culture media and subsequently sterilized, initial ster-
ilization is not necessary.
The NCTC and ATCC numbers are the collection numbers of
strains supplied by these culture collections. This informationidal test method for Clostridium difficile, Journal of Hospital Infection
SPM 5.0 g
KH2PO4 1.30 g
(NH4)2SO4 0.30 g
CaCl2$2H2O 0.04 g
Yeast Extract Powder 5.0 g
K2CO3 1.74 g
MgSO4 0.06 g
ddH2O up to 500mL
BHI 37.0 g
Yeast extract 5.0 g
L-Cysteine 1.0 g
Na taurocholate 1.0 g
Bacteriological agar 15 g
Complete with ddH2O to: 1000 mL
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YJHIN4416_proof ■ 13 November 2014 ■ 7/14is given for the convenience of users and does not constitute an
endorsement of the product named.
Preparation of Clostridium difficile spore suspension from
liquid medium (Clospore). This is based on J. Perez and S.A.
Sattar’ standard operating procedure (University of Ottawa,
Canada; 20 May 2008).
Materials. All available from Sigma‒Aldrich unless otherwise
stated. The list is supplied for the convenience of users; equiv-
alent products may be available from alternative suppliers.
e Clostridium difficile NCTC 11209
e Columbia Broth (QueLab Laboratories, Montreal, QB, Cat.
No. QB-39-1106: 500 g)
e C. difficile-specific agar plates
CLO (bioMe´rieux Cat. No 43431) or.
CDMN agar (Oxoid Cat. No: SR0173 added to CM0601 and
SR0050)
e Special Peptone Mix (SPM) (Oxoid Laboratories, Cat. No.
LP0072)
e Brain Heart Infusion (BHI) (Oxoid Laboratories, Cat. No.
CM0225)
e Yeast Extract Powder (HiMedia, Cat. No. 61001-636) or
Difco (Becton‒Dickinson), USA
e Lysozyme
(Egg white) e Activity 20100 units/mg. (Pharmacia LKB
Biotechnology AB, Uppsala, Sweden)
If unavailable, Lysozyme (Sigma Cat No. L6876), activity
40,000 units; note: use half as much, as is twice as active.
e Trypsin
(Sigma Cat: T0134, Lot: 24H0069 from Porcine
Pancreas.15000 BAEE units/mg.) If unavailable: Trypsin
(Sigma cat. no, T0303)
e Na2HPO4
e NaH2PO4
e KH2PO4
e K2CO3
e CaCl2$2H2O
e (NH4)2SO4
e MgSO4
e Taurocholatic acid sodium salt hydrate (Sigma, Cat. T4009-
259, Batch No. 048K1437)
e L-Cysteine
e 0.1 M sodium phosphate buffer pH 7.0
e Sterile water (either double-distilled water (ddH2O), or
sterile distilled water (sdH2O) suffices)
e Sterile plastic transfer pipettes (Pasteur pipettes)
e 15mL sterile polypropylene tubes (Falcon tubes)
e 50mL sterile polypropylene tubes (Falcon tubes)
e 1 L polycarbonate or high-density polypropylene culture
flasks or Duran flasks.
e 200‒1000 mL pipette and suitable sterile tips
e 20‒100 mL pipette and suitable sterile tips
e 1‒20 mL pipette and suitable sterile tips
e 37C incubator with anaerobic conditions:
Anaerobic Chamber (ACh) with internal incubator at
37  2C.
Or anaerobic jars capable of being incubated at 37 2C,
with anaerobic sachets and indicators (Oxoid Cat. Nos.
AN035A and BR0055B)
e Centrifuge with capacity for larger volumes and capable of
maximum 10,000 g;Please cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014e.g. Beckman Centrifuge Avanti J-25 with rotors JA-25-50
and JLA 16-250;
Heraeus Biofuge Primo R with Sorvall 6  50mL 75007588
rotor;
Eppendorf 5702 with 4  50 mL A-4-38 rotor.
e Appropriate centrifuge tubes, e.g. 50 mL Falcon tubes
e Sonicating water bath (frequency 40 kHz  2 kHz)
e Water bath capable of 70C
Preparation of media and reagents. Note: All agar/broths
used to cultivate C. difficile must be pre-reduced (oxygen
removed) before growth. This is defined as incubation of media
in anaerobic conditions for at least 17 h; all lidded containers of
broth/agar must have loosened lids to allow reduction to occur.
All growth of C. difficile must take place at 37  1C with
anaerobic conditions.
Columbia Broth (CB). Prepare 500mL of Columbia Broth as per
the manufacturer’s instructions (35 g/L from QueLab Brand).
Keep at 4C  2C in cold room or refrigerator.
Clostridium difficile sporulation medium (Clospore) prepara-
tion (500 mL). It is recommended that this medium be pre-
pared by dissolving the reagents in the same order in which
they are described. To a 500 mL Duran bottle add 300 mL of
distilled water and then:To prepare Clospore solid medium, add 15 g/L agar to the
above formulation.
The pH before autoclaving should be 7.9 0.2. If not, adjust
it with KOH. Once sterilized the pH should increase up to
9.0  0.2. Autoclave the flasks using the liquid cycle for 45 min
at 121C (retention time is 20 min).
Wait for 2 or 3 h until the temperature drops tow50e60C,
aliquot 25 mL Clospore into 6 50 mL sterile falcon tubes, or in
500mL batches to give higher yields of spores, and pre-reduce.
After 17 h of pre-reduction and before inoculation, the pH
should drop to 8.2 0.3. After sterilization, the pH can be 8.8‒
8.9 and after 17 h reduction it should drop to 8.7 or less.
Semisolid medium for spore recovery (BHIS). This can be used
for spore enumeration. Alternatively, C. difficile specific agar
plates can be used.idal test method for Clostridium difficile, Journal of Hospital Infection
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YJHIN4416_proof ■ 13 November 2014 ■ 8/14Heat and boil for 1 min, sterilize on liquid cycle, 45 min at
121C. Lysozyme 10mg in 10mL of ddH2O, added by filtration
(0.2 mm sterile membrane).
0.1 M Na phosphate buffer pH 7.0. Weigh 8.1934 g of anhy-
drous Na2HPO4 and 5.8374 g of NaH2PO4$H2O. Dissolve in
w800 mL of ddH2O. Adjust pH to 7.00 with 1 M NaOH or 1 M HCl
and fill to 1000 mL.
Enzymatic solution. Weigh the necessary quantity to prepare a
solution of 20 mg of lysozyme and 15 mg of trypsin per mg of wet
weight spore and dissolve it in 25mL of 0.1 M sodium phosphate
buffer, pH 7.00 (scale amount of enzyme used up/down in case
of use of enzyme with different activity). The spore wet weight
depends on the harvest’s yield. Sterilize the solution through a
maximum pore size of 0.45 mm sterile Millipore filter at the
time you add this solution directly to the centrifuge tube with
the spore suspension to be treated.
Procedure
Note: The liquid culture method is preferable; however, the
solid culture method can be used if access to a centrifuge with
suitable capacity for harvesting (>200 mL total rotor capacity)
is unavailable.
Preparation of liquid culture
Inoculum preparation:.
e From the stock spore suspension kept at 4  2C (or the
original suspension kept at80C) take a loop and spread it
on a reduced CDMN or CLO plate. Incubate the plate for
48 h at 37  1C under anaerobic conditions or until the
colonies are 2e4mm in diameter
e At the same time, keep in anaerobic conditions 15 mL
sterile Falcon tubes containing 5 mL of CB for the pre-
inoculum preparation, and the same number of 50 mL
Falcon tubes with 20mL of CB as number of culture flasks
you have to inoculate, for the inoculum preparation. For
example, 4  500 mL (or 4  25mL) of Clospore broth
require 4 20 mL inoculum CB, which require 4 5mL pre-
inoculum CB.
e Select a colony and resuspend it in a 15 mL sterile plastic
tube containing 5 mL of pre-reduced CB.
e Incubate for 24‒48 h under anaerobic conditions. Inoculate
50 mL into each of 50 mL plastic tubes containing 20 mL of
pre-reduced CB.
e Incubate them for 24‒48 h in the anaerobic chamber.
Flask inoculation:.
e Take the pre-reduced Clospore broth out of anaerobic
conditions and tighten their lids.
e Inoculate each Falcon tube of 25mL Clospore broth with
1 mL of inoculum as fast as you can, without any agitation
or introduction of air bubbles. For larger volumes of broth,
add all 20 mL inoculated CB to 500 mL Clospore broth, in a
similar, steady fashion.
e Return the inoculated flasks to anaerobic conditions
without any agitation, first loosening the lids. Incubate the
flasks without any agitation for 7‒10 days at 37  1C.
e At the end of incubation, assess the number and viability of
spores to calculate the yield of the process.
e For quality control purposes, here one can inoculate a
Lysogeny Broth (LB) or Trypticase Soy Agar (TSA) platePlease cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014(500 mL) and incubate aerobically overnight to check for
absence of growth.
Harvesting liquid culture:.
e Centrifuge the sporulated culture at 10,000 g (or as high as
your rotor allows up to this speed) for 10 min at room
temperature. Discard the supernatant in a waste container
and repeat the process until the total volume of the culture
is centrifuged. Pool the sediment in one centrifuge tube
and wash the pellet up to three times with 25mL of sterile
water.
e Resuspend the pellet in 10mL of sterile water and transfer
the suspension into a previously weighed 50mL centrifuge
tube. Rinse the centrifuge tube several times and complete
the volume to 20mL. Centrifuge at 10,000 g for 10 min and
discard the supernatant.
e Weigh the tube with the pellet and keep it at 4  2C until
the next step. Calculate the obtained wet weight of the
spores. This wet weight should be used to prepare the
enzymatic solution.
Clospore plate method
Inoculum preparation:.
e From the stock spore suspension kept in the cool room (or
the original suspension kept at 80C), take a loop and
spread it on a reduced CDMN/CLO plate. Incubate the plate
for 48 h at 37  2C in anaerobic conditions or until the
colonies are 2e4mm in diameter.
e At the same time, keep in anaerobic conditions 4  15mL
sterile Falcon tubes containing 5 mL of CB for the pre-
inoculum preparation and 40 Clospore plates.
e Select a colony and resuspend it in a 15 mL sterile plastic
tube containing 5 mL of at least 24 h pre-reduced CB.
e Incubate for 16 h in anaerobic conditions.
e Inoculate 40 Clospore plates (90 mm) with 500 mL, spread
evenly over the plate with a sterile spreader and allow
drying at room temperature in a laminar air flow cabinet.
e For quality control purposes, here one can inoculate an LB/
TSA plate (500 mL) and incubate aerobically overnight to
check for absence of growth.
e Incubate anaerobically for 7‒10 days at 37  1C. At the
end of incubation, assess the number and viability of spores
to calculate the yield of the process.
Harvesting for solid culture:.
e Wash each plate by adding 2mL sterile water to a plate,
scraping the surface with a sterile spreader and pipetting
the liquid into a sterile and previously weighed 50mL
centrifuge tube.
e Centrifuge at 10,000 g for 15 min at 4  2C.
e Pour off supernatant and wash up to three times in 30mL
sterile water, discarding the supernatant.
e Weigh the tube and the pellet and keep it in the cold room
until the next step. Calculate the obtained wet weight of
the spores. This wet weight should be used to prepare the
enzymatic solution.
Purification of the spore suspension (both liquid and plate har-
vest):.
e Resuspend the pellet (no more than 1 g of wet weight) in
10mL of 0.1 M sodium phosphate buffer, pH 7.0 and mix
thoroughly in a vortex.idal test method for Clostridium difficile, Journal of Hospital Infection
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YJHIN4416_proof ■ 13 November 2014 ■ 9/14e Add the 20mL freshly prepared enzymatic solution and
gently mix.
e Sonicate the suspension on ice for 60 s, then cool on ice for
30 s, and repeat this cycle once. Incubate the suspension
for 30min at 45C in a water bath. Repeat the sonication‒
water bath step once.
e Centrifuge the suspension at 10,000 g for 10 min and wash
the pellet up to three times with sterile water, resus-
pending in 30mL of sterile water.
e Heat for 10 min at 70C, and then submerge the tube in ice
for 5 min.
e Centrifuge the suspension at 10,000 g for 10 min and
resuspend the sediment in a final volume of 10mL of sterile
water. Transfer it to a sterile plastic tube and keep the
suspension in the cold room at 4  2C.
e Count the spore number and the survivors (see below).
Quality control
Sonication:.
e As C. difficile spores tend to aggregate into clumps over
time, immediately prior to testing, sonication must be
performed.
e As repeated sonication over time can lead to loss of spore
viability, sonication must only be performed on one small
aliquot of spores at a time; enough to perform testing.
e Sonication prior to testing should be performed in a thin-
walled glass vessel for 5 min.No: of cells=mL ¼ average of counted cells=0:0005834 103 for slides
No: of cells=mL ¼ average of counted cells=0:003821 103 for the Neubauer chamber
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129Storage of spores:.
e Storage of spores at 4  2C must be performed for a
minimum of two weeks, to allow for spore maturation.
Immature spores may be more susceptible to disinfectants
and give inaccurate results.
e Spore preparations must be discarded after 12 months of
production, due to loss of viability.
e Prior to testing, the preparation should be assessed for
concentration and percentage of spores.
Assessing spore concentration (cfu/mL). Note: Concentration
of spores/mL can be found by multiplying the percentage
spores seen by microscopy by the cfu/mL concentration.
e Perform a 1-in-10 serial dilution in sterile water of the
spore solution, and assay by plating out duplicate 100 mL
volumes on pre-reduced C. difficile specific agar. Colony-
forming units (cfu) can be counted on duplicate plates.
e Cfu/mL can be calculated by:
cfu
mL
¼ average of cfu on plates 1000
volume plated dilution factor
Alternatively, the Miles‒Misra or other suitable validated
methods can be employed (Miles AA, Misra JO. The estimationPlease cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014of the bactericidal power of the blood. J Hyg 1938;38:
732‒749).
Assessing percentage spores
Phase-contrast microscopy with imaging software:.
e Add10 mLofawell-vortexed solution to the surfaceof a glass
slide and cover with a 22  22 mm cover slide or using an
improvedNeubauer chamber. Itmay benecessary to serially
dilute (101‒102) the suspension, depending on the yield.
e Take random pictures (8e10) in a phase-contrast and epi-
fluorescent microscope: Axioskop 2 Plus, Carl Zeiss with
Lens Plan-Neofluar, Camera Axiocam MRm, Monochrome
Carl Zeiss and MR Grab software 1.0.0.4. by using the 40
objective lens. Process images with the Software Image-Pro
Plus version 5.1 to count the total spore number as highly
refractile (phase-bright) particles present in the sample.
e The factor used for the estimation of the cell concentration
in the microscope slides is calculated considering the pic-
ture area and height for a volume of 10 mL. The theoretical
factor is amended by comparing the spore and cell con-
centration in stock cultures with those obtained with an
improved Neubauer chamber used as standard. The lower
sensitivity for the slide method is 1.2  106/mL and for the
Neubauer chamber 2  105/mL which corresponds to one
cell or spore average per picture (field).
e The final formulae to estimate the cell or spore numbers
are the following:Phase contrast microscopy by eye:.
e Add 10 mL of a well-vortexed spore preparation to the
surface of a glass slide and cover with a 22  22mm cover
slide or using an improved Neubauer chamber. It may be
necessary to serially dilute (101‒102) the suspension,
depending on the yield.
e View under phase contrast and estimate the percentage of
highly refractile, (phase-bright) spores that are present,
compared to debris or dark vegetative cells.
Spore staining method:.
e If phase contrast microscopy equipment is unavailable,
perform a Schaeffer‒Fulton spore stain of 10 mL of final
suspension on a glass slide and estimate percentage of dark
green spores compared to debris or red vegetative cells,
visible under light microscopy.
Increasing spore yield.
e Increasing the volume of liquid or the number of plates
inoculated can give a higher spore yield.
e Decreasing the number of washes during the purification
process can give a higher yield, as spores can be lost from
pellet upon discarding of supernatant. However, too few130
idal test method for Clostridium difficile, Journal of Hospital Infection
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YJHIN4416_proof ■ 13 November 2014 ■ 10/14washes may lead to a decrease in quality, so no fewer than
four washes in total are recommended.1.0 g Tryptone
8.5 g NaCl
1 L Distilled water
68
69
70
71
72
73
74Disinfectant test method
Materials
Standard hard water
Stock solution A:.1.98 g MgCl2 (anhydrous)
4.62 g CaCl2 (anhydrous)
100 mL Distilled water
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951. Weigh out the MgCl2 and CaCl2 and transfer to a 100 mL
volumetric flask.
2. Using a clean measuring cylinder, measure 100mL of
distilled water and add w50 mL to the chemicals. Gently
rotate the flask until the dry chemicals have dissolved.
3. Gradually add the rest of the measured volume of distilled
water to the solution to make up to 100mL.
4. Secure the lid on the bottle and shake thoroughly to mix the
ingredients.
5. Sterilize by autoclaving at 121C for 15min.
Label appropriately. This may be stored at 4  2C for up to
one month prior to use.
Stock solution B:.3.5 g NaHCO3
100 mL Distilled water
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1141. Weigh out the NaHCO3 and transfer to a 100 mL volumetric
flask.
2. Follow steps 2‒4 as described above in the preparation of
solution A.
3. Sterilize using a sterile Millipore unit with a maximum pore
size of 0.45 mm.
4. At the end of the sterilizing procedure, transfer the filtered
media into a sterile 250mL container. This may be stored at
4  2C for up to one month prior to use.
Requirements for preparation of working solution of hard
water
The following volumes are required to produce 100 mL hard
water:0.6 mL Solution A
0.8 mL Solution B
98.6 mL Pre-poured bottle of sterile distilled water
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1301. Aseptically transfer 0.6 mL of solution A to the bottle of
sterile distilled water.
2. Transfer 0.8 mL of solution B to the same bottle of sterile
water.
3. Before immediate use, shake the bottle well in order to mix
the water and solutions.
4. Use on day of preparation.
5. Dispose of any unused hard water after use.Please cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014Diluent1. Weigh out the tryptone and NaCl and transfer to a 1 L
volumetric flask.
2. Add 1 L distilled water.
3. Sterilize by autoclaving at 121C for 15min.Interfering substance
General. The interfering substance shall be chosen according
to the conditions of use laid down for the product.
The interfering substance shall be sterile and prepared at 10
times its final concentration in the test.
The ionic composition (e.g. pH, calcium and/or magnesium
hardness) and chemical composition (e. g. mineral substances,
protein, carbohydrates, lipids and detergents) shall be defined.
Note: The term ‘interfering substance’ is used even if it
contains more than one substance.
Clean conditions (bovine albumin solution: low
concentration)
Dissolve 0.30 g of bovine albumin fraction V (suitable for
microbiological purposes) in 100 mL of diluent.
Sterilize by membrane filtration, store at 4  2C and use
within one month.
The final concentration of the bovine albumin in the test
procedure shall be 0.3 g/L.
Dirty conditions (mixture of bovine albumin solutions:
high concentration with sheep erythrocytes)
Dissolve 3.00 g of bovine albumin fraction V (suitable for
microbiological purposes) in 97 mL of diluent.
Sterilize by membrane filtration.
Prepare at least 8.0 mL fresh sterile defibrinated sheep
blood. Centrifuge the erythrocytes at 800 g for 10 min. After
discarding the supernatant, resuspend erythrocytes in diluent.
Repeat this procedure at least three times, until the superna-
tant is colourless.
Resuspend 3mL of the packed sheep erythrocytes in the
97mL of sterilized bovine albumin solution (see above). To
avoid later contamination this mixture should be split in por-
tions, and kept in separate containers for a maximum of seven
days at 4  2C.
The final concentration of bovine albumin and sheep
erythrocytes in the test procedure shall be 3 g/L and 3mL/L
respectively.
Clean and dirty conditions for the modified method for
ready-to-use products
Follow in general the procedures for preparation, but pre-
pare the interfering substance in fivefold higher concentrations:
(a) Clean conditions: dissolve 1.50 g bovine albumin (instead of
0.3 g) in 100 mL of diluent.
(b) Dirty conditions: dissolve 15.0 g bovine albumin (instead of
3.0 g) in 85 mL of diluent (instead of 97 mL).idal test method for Clostridium difficile, Journal of Hospital Infection
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YJHIN4416_proof ■ 13 November 2014 ■ 11/14Prepare at least 40 mL (instead of 8.0 mL) sheep blood.
Resuspend 15 mL (instead of 3.0 mL) of the packed sheep
erythrocytes in 85 mL of sterilized bovine albumin solution (see
above).
Sterile defibrinated sheep blood
The sterile defibrinated sheep blood can be acquired from a
commercial supplier or prepared according to EN 14820.
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121Working culture of test organism
Use spore suspension prepared as previously described.
Validation of spore stock suspension
Check the viability and the susceptibility of each spore
batch after at least two weeks’ storage at 4  2C. Each test
should include 500 ppm av. Cl2 at 20
C as a validation control.
With Clostridium difficile NCTC 11209 (under clean condi-
tions only):
500 ppm av. Cl2 solution should achieve a log10 reduction of
<1 in 1 min;
500 ppm av. Cl2 solution should achieve a log10 reduction of
5 in 60min.
After validation, store the spore stock suspension at 4  2C
and use within one year.
Test suspension (‘N’)
Adjust the number of spores in the suspension to 1.5 107 to
5  107 cfu/mL using distilled water. Assay the solution by a
validated method [see ‘Assessing spore concentration (cfu/
mL)’ section above]
Validation suspension (‘Nv’)
To prepare the validation suspension (Nv), dilute the test
suspension with diluent to obtain 3.0  102 cfu/mL to
1.6  103 cfu/mL [about one-fourth (1 þ 3) of the 103 dilu-
tion]. Mix.
Note: In the case of the modified method, the procedure is
the same resulting in 3.0  103 cfu/mL to 1.6  104 cfu/mL.
Assay the suspension as previously described.
Maintain and use the validation suspension (Nv) in the same
way as the test suspension.
Incubation and counting of the test and the validation
suspensions
(a) Incubate the plates anaerobically for 72‒120 h. Discard any
plates that are not countable for any reason.
(b) Note: For each plate the exact number of colonies and
determine the Vc values (see below).
(c) Calculate the numbers of cfu/mL in the test suspension ‘N’
and in the validation suspension ‘Nv’ using the methods
given below.122
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130Product test solutions
As it is diluted to 80% during the test and the method vali-
dation, the concentration of a product test solution shall be
1.25 times the desired test concentration.
Product test solutions shall be prepared in hard water. The
product as received may be used as the test solution; in this
case the highest tested concentration is 80%. If ready-to-usePlease cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014products, i.e. products that are not diluted when applied, do
not demonstrate the required reduction, the modified test
procedure may be used in order to test a higher product con-
centration (97%).
Dilutions of ready-to-use products shall be prepared in wa-
ter instead of hard water. The modified method cannot be used
for handwash products, since 62.5% represents the highest
accepted concentration (50%), multiplied by 1.25.
The product test solutions shall be prepared freshly and
used in the test within 2 h. They shall give a physically homo-
geneous preparation, stable during the whole procedure. If
during the procedure a visible inhomogeneity appears due to
the formation of a precipitate or flocculant (for example,
through the addition of the interfering substance), it shall be
recorded in the test report.
Note: Counting micro-organisms embedded in a precipitate
or flocculant is difficult and unreliable.Procedure for assessing the sporicidal activity of the
product
General
Experimental conditions (obligatory and additional). Besides
the obligatory temperature, contact time, interfering sub-
stance, and test organisms, additional experimental conditions
(including test organisms) may be selected according to the
practical use considered for the product:
(a) Temperature (C):
The obligatory temperature to be tested is 20C.
The allowed deviation for each chosen temperature is 
2C.
(b) Contact time, t (in min):
The obligatory contact time to be tested is 1 min for a hand
rub/wash, 5 min for a surface disinfectant, and 5min for an
instrument disinfectant.
The allowed deviation for each chosen contact time is 
10 s, except for 1min where it is 5 s.
(c) Interfering substances:
The obligatory interfering substance to be tested is 0.30 g/L
bovine albumin under clean conditions, or a mixture of 3 mL/L
sheep erythrocytes and 3.0 g/L bovine albumin under dirty
conditions, according to practical applications. Additional
interfering substances may be tested according to specific
fields of application.
(d) Test organism:
Clostridium difficile, NCTC 11209
Additional spore-forming test organisms may be tested but
details on the validation of the spore suspension must be
provided.
Choice of test method
The method of choice is the dilution‒neutralization
method. To determine a suitable neutralizer, carry out the
validation of the dilution‒neutralization method, using aidal test method for Clostridium difficile, Journal of Hospital Infection
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YJHIN4416_proof ■ 13 November 2014 ■ 12/14neutralizer chosen according to laboratory experience and
published data.
If this neutralizer is not valid, repeat the validation test
using an alternative neutralizer.
Note: In special circumstances, it may be necessary to use a
1-in-100 dilution, or a filtration method for neutralization and
recovery.
General instructions for validation and control
procedures
The neutralization and/or removal of the sporicidal and/or
sporistatic activity of the product shall be controlled and
validated ‒ only for the highest product test concentration ‒
for each test organism and for each experimental condition
(interfering substance and temperature). These procedures
(experimental condition control, neutralizer control, and
method validation) shall be performed with the same
neutralizer used in the test.
Equilibration of temperature
Prior to testing, equilibrate all reagents (product test solu-
tions, test suspension, validation suspension, diluent, hard
water, and interfering substance) to the test temperature.
Dilution‒neutralization method
General. The test and the control and validation procedures
should be carried out at the same time.
Test Na: determination of sporicidal efficacy. The procedure
for determining sporicidal efficacy is as follows:
(a) Pipette 1.0 mL of the interfering substance into a tube. Add
1.0 mL of the test suspension, N. Start the stopwatch
immediately, mix, and allow the tube to equilibrate at the
chosen test temperature for 2 min  10 s.
At the end of this time, add 8.0 mL of the product test so-
lution. Restart the stopwatch at the beginning of the addition.
Mix, and place the tube at the required temperature for the
chosen contact time t. Just before the end of t, mix.
(b) At the end of t, take a 1.0 mL sample of the test mixture Na
and transfer into a tube containing 8.0 mL neutralizer and
1.0 mL water. Mix and place at the required temperature.
After a neutralization time of 5 min  10 s, mix and
immediately take a sample of 1.0 mL of the neutralized
test mixture Na (containing neutralizer, product test solu-
tion, interfering substance and test suspension) in dupli-
cate and inoculate using a surface plate technique.
Additionally transfer 1 mL of this mixture into a tube con-
taining 9 mL of diluent to obtain 101 dilution of Na, repeat this
procedure to obtain 102 and 103 dilutions of Na. Take samples
of 1.0 mL from each dilution tube in duplicate and inoculate
using the surface plating technique.
(c) Perform procedures (a) and (b), using any other product
test solutions at the same time.
(d) Perform procedures (a) to (c), applying any additional
experimental conditions.Please cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014Experimental conditions control A: validation of the selected
experimental conditions and/or verification of the absence of
any lethal effect in the test conditions. To validate the
selected experimental conditions and/or to verify the absence
of any lethal effect in the test conditions, the procedure is as
follows:
(a) Pipette 1.0 mL of the interfering substance used in the test
into a tube. Add 1.0 mL of the validation suspension, Nv.
Start the stopwatch immediately,mix, and allow the tube to
equilibrate at the chosen test temperature for 2 min 10 s.
At the end of this time, add 8.0 mL of hard water [In the case
of ready-to-use products (except handwash products), distilled
water is used instead of hard water.] Restart the stopwatch at
the beginning of the addition. Mix and place the tube at the
required temperature for t. Just before the end of t, mix again.
(b) At the end of t, take a sample of 1.0 mL of this mixture A in
duplicate and inoculate using the spread plate technique.
Neutralizer control B: verification of the absence of
toxicity of the neutralizer
To verify the absence of toxicity of the neutralizer, the
procedure is as follows:
(a) Pipette 9.0 mL of the neutralizer used in the test into a
tube. Add 1.0 mL of the validation suspension (Nv). Start
the stopwatch at the beginning of the addition, then mix.
Transfer 1.0 mL of this mixture into a tube containing
8.0 mL of neutralizer and 1.0 mL of distilled water. Mix and
place the tube at the required temperature for
5 min  10 s. Just before the end of this time, mix.
(b) At the end of this time, take a sample of 1.0 mL of this
mixture B in duplicate and inoculate using the surface
plating technique.Method validation C: dilution‒neutralization validation. To
validate the dilution neutralization method, the procedure is
as follows:
(a) Pipette 1.0 mL of the interfering substance used in the test
into a tube. Add 1.0 mL of diluent and then, starting a
stopwatch, add 8.0 mL of the product test solution only of
the highest concentration used in the test. Mix and place
the tube at the required temperature for t. Just before the
end of t, mix again.
(b) At the end of t, transfer 1.0 mL of the mixture into a tube
containing 8.0 mL of neutralizer.
Restart the stopwatch at the beginning of the addition. Mix
and place the tube at the required temperature for 5 min 10 s
(for hand-rub and handwash products only 10 1 s). Add 1.0 mL
of the validation suspension. Start a stopwatch at the beginning
of the addition and mix. Place the tube at the required tem-
perature for 30min  1min. Just before the end of this time,
mix again. At the end of this time, take a sample of 1.0 mL of
the mixture C in duplicate and inoculate using the surface
plating technique.128
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YJHIN4416_proof ■ 13 November 2014 ■ 13/14Incubation and counting of the test mixture and the
control and validation mixtures
For incubation and counting of the test mixture and the
control and validation mixtures, the procedure is as follows:
(a) Incubate the plates anaerobically for 72‒120 h. Discard any
plates that are not countable for any reason. Count the
plates and determine the number of cfu.
(b) Note for each plate the exact number of colonies and
determine the Vc values (see below).
(c) Calculate the numbers of cfu/mL in the test mixture Na and
in the validation mixtures A, B, and C using the method
given below.80
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102Modified dilution‒neutralization method
In the following, only the modifications are described.
Test Na.
(a) Pipette 0.2 mL of the five-fold concentrated interfering
substance into a tube. Add 0.1 mL of the 10-fold concen-
trated test suspension. Start the stopwatch immediately,
mix, and place the tube at the chosen test temperature for
2min  10 s.
(b) At the end of this time, add 9.7 mL of the undiluted product
test solution.
(c) Restart the stopwatch at the beginning of the addition. Mix
and place the tube at the required temperature for the
chosen contact time t. Just before the end of t, mix again.
(d) Follow the subsequent instructions for the unmodified
method.103
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120Experimental conditions control A: validation of the selected
experimental conditions and/or verification of the absence of
any lethal effect in the test conditions.
(a) Pipette 0.2 mL of the interfering substance used in the test
into a tube. Add 0.1 mL of the 10-fold-concentrated vali-
dation suspension as described for this modified method.
Start the stopwatch immediately, mix, and place the tube
at the required temperature for 2 min  10 s.
(b) At the end of this time, add 9.7 mL of water. Restart the
stopwatch at the beginning of the addition.
(c) Follow the subsequent instructions for the unmodified
method.121
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130Neutralizer control B: verification of the absence of toxicity
of the neutralizer. Follow the procedure as described in the
unmodified method.
Method validation C: dilution‒neutralization validation.
(a) Pipette 0.2 mL of the interfering substance used in the test
into a tube. Add 0.1 mL of diluent. Then, starting aPlease cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014stopwatch, add 9.7 mL of the product test solution. Mix and
place the tube at the required temperature for t. Just
before the end of t, mix again.
(b) At the end of t, transfer 1.1 mL of the mixture into a tube
containing 8.8 mL of neutralizer.
Restart the stopwatch at the beginning of the addition. Mix
and place the tube at the required temperature for 5 min 10 s
(for hand-rub and handwash products only for 10  1 s). Add
0.1 mL of the 10-fold-concentrated validation suspension as
described for this modified method. Start a stopwatch at the
beginning of the addition and mix. Place the tube at the
required temperature for 30min  1min. Just before the end
of this time, mix again.
At the end of this time, take a sample of 1.0 mL of the
mixture C in duplicate and inoculate using the spread plate
technique.Calculation
General
The first step in the calculation is the determination of the
Vc values, the second the calculation of N, N0, Na, Nv, Nv0, A, B,
and C. The third step is the calculation of the reduction R.
Determination of Vc values
(a) Determine the number of cfu on each plate, using only
those plates where colonies are well separated.
(b) For counting the test suspension N, the validation suspen-
sion Nv, and for all counts of the dilution‒neutralization
method, determine and record the Vc values according to
the number of plates used per 1 mL sample.
Note: If more than one plate per 1 mL sample has been used
to determine the Vc value, the counts per plate should be
noted.
Calculation of N and N0
N is the number of cells per mL in the test suspension. If two
dilutions of the test suspension are evaluated, calculate the
number of cfu/mL as the weighted mean count:
N ¼ c
n1 þ n2 =10

106
where c is the sum of Vc values taken into account, n1 is the number of
Vc values taken into account in the lower dilution, i.e. 10
6, n2 is the
number of Vc values taken into account in the higher dilution, i.e. 10
7,
and 106 is the dilution factor corresponding to the lower dilution.
Note: For the modified method, N is 10-fold higher and
therefore the dilutions to be evaluated are 10-fold higher. The
formula above has to be changed accordingly. N0 is the number
of cells per mL in the test mixture at time ‘zero’. It is one-tenth
(one-hundredth in the modified method) of the weighted mean
of N due to the dilution by the addition of the product and
interfering substance.
Calculation of Na
Na is the number of survivors per mL in the test mixture
at the end of the contact time and before neutralization. It isidal test method for Clostridium difficile, Journal of Hospital Infection
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YJHIN4416_proof ■ 13 November 2014 ■ 14/1410-fold higher than the Vc values due to the addition of
neutralizer and water.
Calculate the mean for each dilution step N0a, N
1
a , etc.,
using the following formula:
Na ¼ 10 c
n
where c is the sum of Vc values taken into account, and n is the number
of Vc values taken into account.
Calculation of Nv and Nv0
Nv is the number of cells per mL in the validation suspension.
It is 10-fold higher than the counts in terms of Vc values due to
the dilution step. Nv0 is the number of cells per mL in the
mixtures A, B, and C at the beginning of the contact time (time
zero). Calculate Nv and Nv0 using the following formulae:
Nv ¼ 10 c
n
Nv0 ¼ c=n
where c is the sum of the Vc values taken into account and n is the
number of Vc values taken into account.
Calculation of A, B, and C
A, B, and C are the numbers of survivors in the experimental
conditions control A, neutralizer control B, and method vali-
dation C. They correspond to mean of the Vc values of the
mixtures A, B, and C. Calculate A, B, and C using the following
formula:
A; B;C ¼ c=n
where c is the sum of Vc values taken into account and n is the number
of Vc values taken into account.
Expression of results
The reduction R is the logarithmic ratio of N0 to Na. For each
product concentration and experimental condition, calcu-
late the decimal log10 reduction using the formula:
R ¼ logN0  logNa
Interpretation of results: conclusion
General
According to the chosen experimental conditions (obligatory
or obligatory and additional) the sporicidal concentrations
determined according to this standard may differ. A product
can only pass the test if A, B, and C are  0.5  Nv0.
Sporicidal activity for surface disinfection products
The product shall be deemed to have passed this method if
it demonstrates in a valid test for surface disinfection products
a reduction of 5 log10 within 5 min for products used on
surfaces.Please cite this article in press as: Fraise AP, et al., Development of a sporic
(2014), http://dx.doi.org/10.1016/j.jhin.2014.09.014The test will be considered valid if the validation test using
500 ppm av. Cl2 solution under clean conditions only
demonstrates:
<1 log10 in 1 min.
5 log10 reduction in 60 min.
If these criteria are not met, the test is not valid.References
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